CIDRAP newsletters options
Chinese officials have reported two H7N9 infections that occurred between September and Oct 10, but no details about the cases were available. The infections were noted in a government National Health and Family Planning Commission notifiable diseases overview in Chinese published on Oct 10 that was flagged, translated, and posted by FluTrackers, an infectious disease news message board.
The chikungunya outbreak in the Caribbean and the Americas continued to expand slowly, as the Pan American Health Organization (PAHO) added 3,409 new cases in its weekly update published late last week.
The nurse is hospitalized months after her initial infection, and the vaccine trial has begun in Sierra Leone.
Vaccine effectiveness (VE) for both US-approved rotavirus vaccines— the five-strain (RV5) and single-strain (RV1) versions—is 80% in children, according to a study published yesterday in Clinical Infectious Diseases.
Evidence didn't support routine use for seasonal flu, and the group said research is needed during epidemics.
Administering tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine together with the flu vaccine during pregnancy was found as safe as administering them sequentially, according to a retrospective cohort study published this week in Obstetrics & Gynecology.
Inadequate measles vaccination coverage places one in eight US kids at risk for contracting the disease and one in four of those 3 years old or younger, according to data presented today at IDWeek in San Diego, the Infectious Diseases Society of America (IDSA), a sponsor of the conference, reported today in a press release.
Cases were at the lowest point since the outbreak was first reported in March 2014.
Jordan's health ministry today reported another MERS-CoV case, involving a 53-year-old man who had contact with an earlier case, according to a report from Kuwait News Agency (KUNA). The story's Amman dateline and the man's status as a contact suggest that his infection is likely related to a hospital outbreak in the Jordanian capital.
The multistate outbreak of salmonellosis linked to imported cucumbers has grown by 61 cases, to 732, and an additional death has been reported, the Centers for Disease Control and Prevention (CDC) said yesterday in an update.
One more state is affected, bringing that total to 35, the CDC said. The outbreak has now caused four deaths.
Surveillance found geographic variability that points to the need for regional strategies that target the CRE threat.
Influenza activity worldwide remains low, with upticks in some Asian and Latin American countries, the World Health Organization (WHO) said yesterday in an update.
Despite suspected MERS, the Saudi man's body can't be tested due to embalming.
The seasonal flu vaccine might cut the risk of contracting flu-associated pneumonia acquired in the community by more than half, a study today in the Journal of the American Medical Association (JAMA) found.
An emergency committee established to advise the World Health Organization (WHO) on Ebola outbreak response steps met for the seventh time last week and today announced that ongoing transmission and other factors still meet the threshold for a public health emergency of international concern (PHEIC) as defined by the International Health Regulations.
The NSABB plans to release final recommendations in spring 2016.
Healthcare workers (HCWs) in Guinea last year had an incidence of Ebola virus disease 42 times higher than non-HCWs, and lab technicians, physicians, and men were especially hit hard, according to a report today in Morbidity and Mortality Weekly Report (MMWR).
Two of four Jordan cases involve health workers, and contact info in a Riyadh case is being probed.
The Department of Health and Human Services (HHS) is funding two projects to aid in developing better seasonal flu vaccines and in improving pandemic flu preparedness, the agency said in a news release yesterday.
NewLink Genetics today announced that the federal government has exercised an $18 million option to ramp up the production of its experimental Ebola vaccine VSV-EBOV, according to a statement from the company. The company has licensed the vaccine from the Public Health Agency of Canada, the developer of the vaccine, which is furthest along in clinical studies in the West African outbreak region.
